(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202509 | 202409 | % Var | 202509 | 202409 | % Var | 202503 | 202403 | % Var | |
| Sales | 15386.60 | 26360.99 | -41.63 | 39335.88 | 49656.36 | -20.78 | 92264.09 | 78911.19 | 16.92 |
| Other Income | 2857.56 | 830.77 | 243.97 | 3550.91 | 1387.25 | 155.97 | 3563.66 | 11680.24 | -69.49 |
| PBIDT | 1077.58 | 8617.03 | -87.49 | 9052.52 | 15484.53 | -41.54 | 26005.46 | 24096.87 | 7.92 |
| Interest | 233.96 | 117.95 | 98.36 | 388.54 | 271.44 | 43.14 | 487.33 | 2771.10 | -82.41 |
| PBDT | -8474.32 | 8499.08 | -199.71 | -3886.28 | 15213.09 | -125.55 | 23726.47 | 72029.08 | -67.06 |
| Depreciation | 589.34 | 548.49 | 7.45 | 1165.73 | 1079.36 | 8.00 | 2186.29 | 2021.62 | 8.15 |
| PBT | -9063.66 | 7950.59 | -214.00 | -5052.01 | 14133.73 | -135.74 | 21540.18 | 70007.46 | -69.23 |
| TAX | -1671.77 | 2000.03 | -183.59 | -962.38 | 3645.86 | -126.40 | 5436.68 | 18334.55 | -70.35 |
| Deferred Tax | -970.05 | 615.40 | -257.63 | -962.38 | 1181.39 | -181.46 | 2275.81 | 7834.63 | -70.95 |
| PAT | -7391.89 | 5950.56 | -224.22 | -4089.63 | 10487.87 | -138.99 | 16103.50 | 51672.91 | -68.84 |
| Equity | 282.20 | 282.19 | 0.00 | 282.20 | 282.19 | 0.00 | 282.19 | 282.19 | 0.00 |
| PBIDTM(%) | 7.00 | 32.69 | -78.58 | 23.01 | 31.18 | -26.20 | 28.19 | 30.54 | -7.70 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: